Following positive Phase IIb trial results, RH5.1/Matrix-M could be the first blood-stage malaria vaccine brought to market.

The RH5.1/Matrix-M blood-stage malaria vaccine shows promise as a crucial secondary defence against malaria, complementing ...

The first blood-stage malaria vaccine RH5.1/Matrix-M has the potential to be a component within a developing malaria vaccine strategy, said a report on Thursday.

The global fight against malaria has taken a significant leap forward with the development of the first blood-stage malaria vaccine, RH5.1/Matrix-M. According to a report released by GlobalData, a ...

Adaptive immunity is the protection of a host organism from a pathogen or toxin. It is mediated by B cells and T cells, and is characterized by immunological memory. Adaptive immunity is highly ...

Introduction: The global climatic changes pose a substantial threat to the well-being and productivity of both humans and animals. Methods: This study examined the impact of climate changes during ...